New global survey data from BioInformatics’ Beyond the Bench series reveals that 87% of scientists and researchers are now using AI for work-related research tasks, up from 75% in 2023. But this dramatic rise in adoption is being tempered by a wave of caution: issues around data fidelity, trust, training, and real-world usability are becoming impossible to ignore.
This study—based on responses from 408 academic, industry, and government researchers—offers a revealing snapshot of how AI is reshaping the life sciences. The findings paint a picture of rapid experimentation paired with mounting institutional hesitation.
AI is Everywhere—But Is It Delivering?
While usage is high, satisfaction is mixed. Only 27% of avid users say AI brings high value to their workflows, despite widespread deployment. The gap between adoption and impact is widening—highlighting a disconnect between what AI promises and what it currently delivers in real-world lab environments.
Researchers cite faster data processing and throughput as AI’s most significant benefits. Yet when it comes to complex tasks—like interpreting experimental outcomes or guiding diagnostics—confidence drops sharply.
“These findings show that value is conditional,” said Richa Singh, VP of Market Insights at BioInformatics. “For AI to move from curiosity to critical tool, vendors need to address usability, trust, and real-world application.”
Who’s Leading the Charge?
When asked which companies are making the biggest impact with AI in life sciences, researchers named:
- Microsoft
- Thermo Fisher Scientific
- Google DeepMind
These tech-forward organizations are gaining traction not just for their models, but for how they’re integrating AI into existing scientific ecosystems. The trend underscores the growing convergence of big tech and biotech—a space once ruled by silos, now increasingly defined by partnerships.
Barriers Still Blocking the Lab Door
Despite enthusiasm, three critical issues continue to stall wider AI implementation:
- Lack of regulatory clarity
- Insufficient user training
- Organizational infrastructure gaps
These aren’t minor speed bumps—they’re major structural challenges that make AI risky for applications requiring precision and compliance. In life sciences, where one flawed model output could skew entire research programs, trust isn’t optional. It’s foundational.
And while most researchers want tools that save time, they’re wary of “black box” models that deliver answers without transparency or traceability.
Pressure to Perform Meets Pressure to Transform
The timing of these findings couldn’t be more crucial. With budgets tightening and the demand for faster results growing, life science organizations are leaning into AI as a way to streamline operations and boost productivity. But many are learning the hard way that AI isn’t plug-and-play—especially in regulated or high-stakes environments.
The report also highlights a broader sentiment shift: Scientists are no longer asking whether AI will be part of their work—they’re asking how to make it truly useful.
What’s Next for Vendors?
For AI solution providers in the life sciences, the message is clear:
- Solve for usability
- Demystify the technology
- Invest in customer education and infrastructure support
There’s significant opportunity for vendors who can bridge the trust gap and tailor solutions for scientists’ actual workflows—not just sell hype.
Power Tomorrow’s Intelligence — Build It with TechEdgeAI.
